HPV Status and Prognosis
Doctors will be able to use the results to classify these cancers as HPV positive or negative and offer treatment accordingly.
Risk of death from HPV positive oropharyngeal cancer to be between 50-80 per cent lower than HPV negative tumors but patients are usually younger so may face a lifetime of treatment-related side effects.
Classifying the HPV status of the cancer can offer eligible patients less intensive treatment with reduced side-effects. “get the most appropriate treatment for their cancer”.
HPV-positive oropharyngeal cancers have better outcomes and fewer relapses after treatment than HPV-negative cancers.
HPV vaccine strategy is under development is some territories (Austria) for males and females